Literature DB >> 3222587

Quality of life in early heart failure. The study of men born in 1913.

H Eriksson1, K Svärdsudd, B Larsson, L Welin, L O Ohlson, G Tibblin, L Wilhelmsen.   

Abstract

To see whether well-being and quality-of-life are affected in congestive heart failure (CHF), a number of health variables, self-assessed and objectively measured, were estimated among 67-year-old men sampled from the general population of Gothenburg, Sweden. Based on history, physical examination and drug treatment, 407 men were studied and grouped into 4 stages of CHF, ranging from no signs or symptoms of CHF to advanced CHF. Men with CHF had more of other cardiovascular disease manifestations, utilized more health care, and reported less well-being and a higher rate of self-assessed disability than men with no CHF. These quality-of-life changes were found not only in the overt cases but also in early CHF. Regardless of CHF stage, quality-of-life seemed more affected in men on drug treatment, compared with those not treated.

Entities:  

Mesh:

Year:  1988        PMID: 3222587     DOI: 10.3109/02813438809009310

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  5 in total

1.  Aspects of quality of life on treatment with felodipine.

Authors:  E Dimenäs; M A Wallander; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Evaluation of three methods of symptom reporting in a clinical trial of felodipine.

Authors:  M A Wallander; E Dimenäs; K Svärdsudd; I Wiklund
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 3.  The pharmacoeconomics of ACE inhibitors in chronic heart failure.

Authors:  J McMurray; A Davie
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 4.  A review of quality-of-life evaluations in patients with congestive heart failure.

Authors:  C Berry; J McMurray
Journal:  Pharmacoeconomics       Date:  1999-09       Impact factor: 4.981

Review 5.  Effect of drug treatment on quality of life in mild to moderate heart failure.

Authors:  D G Waller
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.